MENU
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioMarin Pharmaceutical (BMRN) Earnings Date & Reports
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BMRN is expected to report earnings to rise 24.66% to 94 cents per share on August 04
Q2'26
Est.
$0.95
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.31
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.61
The last earnings report on May 04 showed earnings per share of 75 cents, beating the estimate of 74 cents. With 797.97K shares outstanding, the current market capitalization sits at 11.52B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of innovative pharmaceuticals for serious diseases & medical conditions
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3221
Web
https://www.biomarin.com